Research at HERC
Our purpose is to contribute through our research to health and healthcare in the UK and internationally. We examine the economic aspects of health and disease, the costs and benefits of prevention and treatment, and the design and evaluation of health systems. Of particular importance in all areas is the rigour and innovativeness of the research methods we use.
Read more
© nylsmkt
Genomic Technology
HERC is involved in analysing the economic implications in several studies in the area of genomic technologies. These studies span numerous disease areas including cancers, cardiovascular disease and infectious diseases within hospitals and use a range of health economics tools, especially micro-costing, modelling and discrete choice experiments
Study with us
The Nuffield Department of Population Health has a full-time three year DPhil programme intended to train new researchers in Population Health. The deadline for applications for the academic year 2016 - 17 has now closed.
Read more
HERC Newsletter Issue 16
Read moreThe Health Economics Research Centre (HERC)
HERC was established by the University of Oxford in 1996. Our aim is to contribute to health and healthcare in the UK and internationally, by conducting research on economic aspects of health and disease, the costs and benefits of prevention and treatment, and the design and evaluation of health systems.
Selected Publications
-
Are lower levels of red blood cell transfusion more cost-effective than liberal levels after cardiac surgery? Findings from the TITRe2 randomised controlled trial
Stokes EA. et al, (2016), BMJ Open
-
Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
Herrington W. et al, (2016), The Lancet Diabetes and Endocrinology
-
Economic burden of non-malignant blood disorders across Europe: a population-based cost study
Luengo-Fernandez, R et al, (2016), The Lancet Haematology
-
Economic burden of malignant blood disorders across Europe: a population-based cost analysis
Burns, R et al, (2016), The Lancet Haematology
-
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs
Seamus Kent et al, (2016), Circulation: Cardiovascular Quality and Outcomes
-
Women's birth place preferences in the United Kingdom: a systematic review and narrative synthesis of the quantitative literature.
Hollowell J. et al, (2016), BMC Pregnancy Childbirth, 16
Forthcoming HERC Courses
Introduction to Health Economic Evaluation
13 OCTOBER 2016, Oxford. Limited places available - please use the booking form to reserve a place.
14 OCTOBER 2016, Oxford. This course is currently full but please use the booking form if you would like to be placed on the Waiting List.
Applied Methods of Cost-Effectiveness Analysis
07-09 DECEMBER 2016, Oxford. This course is currently full but please use the booking form if you would like to be placed on the Waiting List.
Follow Us
Founded in 1996
30+ Researchers
Over 1000 course participants
4000+ followers on social media
Forthcoming HERC Seminar
A Brief History of Economic Evaluation.
Professor Philip Clarke, Melbourne School of Population and Global Health, University of Melbourne
Tuesday 20 September 2016, 12:00 pm